Accelerate Diagnostics (AXDX)

• Market cap: $17.5M
• 1 day: -0.86%
• 5 days: -18.60%
• 1 month: -32.69%
• 3 months: -44.44%
• 6 months: -61.96%
• Year to date: -44.44%
• 1 year: -25.55%
• 5 years: -99.07%
• 10 years: -99.69%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Employees: 107

0.7000 USD

-0.0061

0.86%

At close Apr 2, 4:00 PM EDT

1 day

-0.86%

5 days

-18.60%

1 month

-32.69%

3 months

-44.44%

6 months

-61.96%

Year to date

-44.44%

1 year

-25.55%

5 years

-99.07%

10 years

-99.69%

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

4% more funds holding

Funds holding: 46 [Q3] → 48 (+2) [Q4]

1.46% less ownership

Funds ownership: 20.3% [Q3] → 18.84% (-1.46%) [Q4]

32% less capital invested

Capital invested by funds: $8.33M [Q3] → $5.69M (-$2.64M) [Q4]

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K